Opinion|Videos|July 2, 2024
Experts Discuss Long-Term Effects and Monitoring in AD Therapy
Medical experts discuss the long-term consequences of extended use of topical corticosteroids or calcineurin inhibitors in atopic dermatitis (AD) patients and recommend appropriate monitoring strategies.
Advertisement
Episodes in this series
- What are the implications of long-term use of topical corticosteroids or calcineurin inhibitors in AD patients, and how should patients be monitored for these?
- Also discuss how to address concerns related to systemic exposure/absorption of topical corticosteroids
- What factors do you consider when deciding between topical and systemic therapies for patients needing treatment for AD?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency
2
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
3
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
4
Pulmonary Fibrosis and Sexual Health: A Q&A With Na’ama Avitzur, MD
5
